Literature DB >> 2042648

The role of growth hormone and insulin-like growth factor-I in experimental renal growth and scarring.

A M el Nahas1.   

Abstract

Recent evidence suggests a causal link between early renal/glomerular hypertrophy and late kidney scarring and glomerular sclerosis. Insulin-like growth factor-I (IGF-I) is a growth-promoting peptide likely to play a role in the development of kidney growth. We observed an increased renal IGF-I content in two experimental models of accelerated kidney growth in the rat. By contrast, diabetic renal hypertrophy is abolished in the absence of growth hormone (GH). Dietary protein manipulations affect the expression of compensatory renal growth (CRG), as well as renal IGF-I content. The renotrophic effect of a high-protein diet on CRG seems GH-dependent and IGF-I-mediated. GH also appears to have a permissive role on the development of progressive renal scarring following extensive renal ablation in rats, as dwarf rats seem somewhat resistant to the development of accelerated scarring and renal failure.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2042648     DOI: 10.1016/s0272-6386(12)80350-7

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  4 in total

1.  The effects of type 1 IGF receptor inhibition in a mouse model of diabetic kidney disease.

Authors:  Ariel Troib; Daniel Landau; Jack F Youngren; Leonid Kachko; Ralph Rabkin; Yael Segev
Journal:  Growth Horm IGF Res       Date:  2011-08-23       Impact factor: 2.372

2.  Insulin-like growth factor-I stimulates differentiation of ATII cells to ATI-like cells through activation of Wnt5a.

Authors:  Manik C Ghosh; Vijay Gorantla; Patrudu S Makena; Charlean Luellen; Scott E Sinclair; Andreas Schwingshackl; Christopher M Waters
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2013-05-24       Impact factor: 5.464

Review 3.  The role of macrophages during acute kidney injury: destruction and repair.

Authors:  Hwa I Han; Lauren B Skvarca; Eugenel B Espiritu; Alan J Davidson; Neil A Hukriede
Journal:  Pediatr Nephrol       Date:  2018-01-30       Impact factor: 3.714

4.  ACE Inhibition in Anti-Thy1 Glomerulonephritis Limits Proteinuria but Does Not Improve Renal Function and Structural Remodeling.

Authors:  Peter E Westerweel; Jaap A Joles; Krista den Ouden; Roel Goldschmeding; Maarten B Rookmaaker; Marianne C Verhaar
Journal:  Nephron Extra       Date:  2012-01-26
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.